242 related articles for article (PubMed ID: 25881775)
1. A National Evaluation of Door-to-Imaging Times among Acute Ischemic Stroke Patients within the Veterans Health Administration.
Sauser K; Bravata DM; Hayward RA; Levine DA
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1329-32. PubMed ID: 25881775
[TBL] [Abstract][Full Text] [Related]
2. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
[TBL] [Abstract][Full Text] [Related]
3. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
[TBL] [Abstract][Full Text] [Related]
5. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
[TBL] [Abstract][Full Text] [Related]
6. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
[TBL] [Abstract][Full Text] [Related]
7. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
Sauser K; Levine DA; Nickles AV; Reeves MJ
JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
[TBL] [Abstract][Full Text] [Related]
8. Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.
Lin CB; Cox M; Olson DM; Britz GW; Constable M; Fonarow GC; Schwamm L; Peterson ED; Shah BR
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26201547
[TBL] [Abstract][Full Text] [Related]
9. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
[TBL] [Abstract][Full Text] [Related]
10. Variability and Delay in Telestroke Physician Alert among Spokes in a Telestroke Network: A Need for Metric Benchmarks.
Jagolino-Cole AL; Bozorgui S; Ankrom CM; Vahidy F; Bambhroliya AB; Randhawa J; Trevino AD; Cossey TC; Savitz SI; Wu TC
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104332. PubMed ID: 31439524
[TBL] [Abstract][Full Text] [Related]
11. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
13. Predictors of rapid brain imaging in acute stroke: analysis of the Get With the Guidelines-Stroke program.
Kelly AG; Hellkamp AS; Olson D; Smith EE; Schwamm LH
Stroke; 2012 May; 43(5):1279-84. PubMed ID: 22442169
[TBL] [Abstract][Full Text] [Related]
14. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
15. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
[TBL] [Abstract][Full Text] [Related]
16. Does symptom onset to primary stroke center time goals affect stroke outcome?
Chee B; Raman R; Ernstrom K; Guzik AK; Hemmen TM; Rapp KS; Meyer BC; Meyer DM
J Stroke Cerebrovasc Dis; 2014; 23(5):993-1000. PubMed ID: 24103670
[TBL] [Abstract][Full Text] [Related]
17. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative.
Fonarow GC; Smith EE; Saver JL; Reeves MJ; Hernandez AF; Peterson ED; Sacco RL; Schwamm LH
Stroke; 2011 Oct; 42(10):2983-9. PubMed ID: 21885841
[TBL] [Abstract][Full Text] [Related]
18. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
19. Components and Trends in Door to Treatment Times for Endovascular Therapy in Get With The Guidelines-Stroke Hospitals.
Menon BK; Xu H; Cox M; Saver JL; Goyal M; Peterson E; Xian Y; Matsuoka R; Jehan R; Yavagal D; Gupta R; Mehta B; Bhatt DL; Fonarow GC; Schwamm LH; Smith EE
Circulation; 2019 Jan; 139(2):169-179. PubMed ID: 30586703
[TBL] [Abstract][Full Text] [Related]
20. 24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.
Moran JL; Nakagawa K; Asai SM; Koenig MA
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1148-1152. PubMed ID: 26907680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
